HQ Function

Primary hub for research and development of its COBRA™ platform and T-cell engager immunotherapies, including preclinical research, process development, and clinical trial management.

Notable Features:

Located in a modern biotech park, the facility likely housed state-of-the-art laboratories for antibody engineering, cell biology, and bioanalytical work, alongside office spaces.

Work Culture:

As a venture-backed biotech, Maverick fostered an innovative, fast-paced, and science-driven work culture. Emphasis was placed on collaboration, scientific excellence, and a shared mission to develop transformative cancer therapies.

HQ Significance:

The Brisbane headquarters was the nerve center for Maverick's pioneering work on conditionally active T-cell engagers, leading to the development of its lead candidates and ultimately attracting acquisition by Takeda.

Values Reflected in HQ: The headquarters likely reflected values of innovation, scientific rigor, collaboration, and a strong focus on addressing unmet needs in oncology for patients.

Location:

Prior to its acquisition by Takeda, Maverick Therapeutics' operations were primarily concentrated in the United States, with its headquarters and R&D activities based in Brisbane, California. It did not have a significant independent global operational footprint. Post-acquisition, its innovative COBRA™ platform and pipeline assets contribute to Takeda's global oncology research and development programs, which span multiple countries.

Street Address:

2000 Sierra Point Parkway, Suite 400

City:

Brisbane

State/Province:

CA

Country:

USA